← Back to Clinical Trials
Recruiting NCT06262269

NCT06262269 Interest of Adapted Physical Activity by Tele-rehabilitation in Chronic Pathology - Idiopathic Scoliosis in Adolescents

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06262269
Status Recruiting
Phase
Sponsor Association des Paralysees de France (APF)
Condition Adolescent Idiopathic Scoliosis
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2022-09-21
Primary Completion 2026-07

Eligibility & Interventions

Sex Female only
Min Age 13 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
Home-based adapted physical activity program supervised by an APA teacher via individual video conference.First period of the home-based adapted physical activity program with an exercise booklet.Second period of the home-based adapted physical activity program with an exercise booklet.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2022-09-21 with a primary completion date of 2026-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is a randomised controlled trial designed to compare two adapted physical activity treatments for adolescent idiopathic scoliosis (AIS). The main hypotheses it aims to address are as follows: * Treatment with a HIIT (High-Intensity Interval Training) type training program via tele-rehabilitation, supervised by an adapted physical activity teacher, is effective in AIS. * A 12-week physical activity program maintains this efficacy over the long term. To test this hypothesis, Two groups of adolescents will be evaluated: a first group made up of non-athletic adolescents suffering from Idiopathic Scoliosis who will benefit from a tele-rehabilitation (physical activity sessions at home supervised by a teacher in adapted physical activities by video). A second group, control, also made up of non-athletic adolescents suffering from Idiopathic Scoliosis who will benefit from a self-program at home consisting of exercises specific to their scoliosis.

Eligibility Criteria

Inclusion Criteria: * Affiliated to a social security system * Having signed the consent after clear and fair information adapted to her age * Obtained signed consent from at least 1 of the 2 parents or holders of parental authority, after clear and fair information * Subject presenting an AIS defined by the existence of a three-dimensional deformity three-dimensional deformity of the spine associating a frontal deviation measured by by the frontal radiographic angle of Cobb which must be at least 15°, but less than 40°, and a vertebral rotation attested by the presence of a presence of at least 5° of gibbosity on Bunnel's scoliometer. * Subject with front and side radiographs of the total spine, according to the EOS EOS technique, under load, less than 3 months old * Risser test \< 4/5 (EOS radiographs less than 3 months old) * Subject not practicing any regular extracurricular physical activity (including regular (regular = at least 1 hour per week), for at least 6 months. * Internet connection at home allowing tele-rehabilitation in a dedicated a dedicated room for the time of the session with a free surface of minimum 4m² on the floor, without any obstacle up to the ceiling. * Compatibility with the technical requirements: access to a screen screen (computer or laptop, tablet...), with a minimum size of 8 inches (diagonal of 8 inches (diagonal of 20 cm), with an integrated or connected HD webcam connected, and a good quality sound, screen placed on a stable surface surface with a minimum height of 75cm and enough distance to see the to perceive from the camera the whole working area (4m²). Exclusion Criteria: (One criterion is sufficient for non-inclusion) * Subject with secondary scoliosis: neurological, orthopedic, malformative... * Placement of a corset or rehabilitation for less than 3 months * BMI ≤15 or ≥ 30 * Partial or total medical contraindication of any kind to the sports practice (examples: heart disease, unbalanced diabetes, juvenile polyarthritis, chronic painful joint pathology limiting physical performance, osteochondrosis of growth type Osgood-Schlater, Sever, Sinding-Larsen, osteochondritis, surgical sequelae limiting physical performance...) * Inability to undergo the medical follow-up of the trial for psychological social or geographical reasons.

Contact & Investigator

Central Contact

Guyomard Alice

✉ alice.guyomard@marcsautelet.fr

📞 +330614399542

Principal Investigator

Jean-François Catanzariti, Dr.

PRINCIPAL INVESTIGATOR

Association des Paralysés de France

Frequently Asked Questions

Who can join the NCT06262269 clinical trial?

This trial is open to female participants only, aged 13 Years or older, up to 17 Years, studying Adolescent Idiopathic Scoliosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06262269 currently recruiting?

Yes, NCT06262269 is actively recruiting participants. Contact the research team at alice.guyomard@marcsautelet.fr for enrollment information.

Where is the NCT06262269 trial being conducted?

This trial is being conducted at Villeneuve-d'Ascq, France.

Who is sponsoring the NCT06262269 clinical trial?

NCT06262269 is sponsored by Association des Paralysees de France (APF). The principal investigator is Jean-François Catanzariti, Dr. at Association des Paralysés de France. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology